​

Lyra Therapeutics (LYRA) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChart

Lyra Therapeutics Revenue Highlights

Latest Revenue (Y)

$1.53M

Latest Revenue (Q)

$195.00K

Lyra Therapeutics Revenue by Period

Lyra Therapeutics Revenue by Year

DateRevenueChange
2024-12-31$1.53M-1.54%
2023-12-31$1.56M14.31%
2022-12-31$1.36M378.25%
2021-12-31$285.00K100.00%
2020-12-31-100.00%
2019-12-31--100.00%
2018-12-31$1.24M-

Lyra Therapeutics generated $1.53M in revenue during NA 2024, up -1.54% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

Lyra Therapeutics Revenue by Quarter

DateRevenueChange
2024-09-30$195.00K-67.39%
2024-06-30$598.00K12.41%
2024-03-31$532.00K264.38%
2023-12-31$146.00K-73.16%
2023-09-30$544.00K18.78%
2023-06-30$458.00K11.71%
2023-03-31$410.00K3627.27%
2022-12-31$11.00K-96.94%
2022-09-30$359.00K-11.79%
2022-06-30$407.00K-92.42%
2022-03-31$5.37M1880.44%
2021-12-31$271.00K1835.71%
2021-09-30$14.00K100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31-100.00%
2019-12-31-100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31--

Lyra Therapeutics generated $195.00K in revenue during Q3 2024, up -67.39% compared to the previous quarter, and up 42.58% compared to the same period a year ago.

Lyra Therapeutics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
CTMXCytomX Therapeutics$138.10M$33.43M
DAWNDay One Biopharmaceuticals$131.16M$20.07M
SPROSpero Therapeutics$47.98M$13.47M
AUTLAutolus Therapeutics$10.12M-
NUVBNuvation Bio$7.87M$727.00K
BOLTBolt Biotherapeutics$7.69M$1.14M
LYRALyra Therapeutics$1.53M$195.00K
CGEMCullinan Oncology--
ACHLAchilles Therapeutics--
NXTCNextCure--
TILInstil Bio--
ASMBAssembly Biosciences-$6.84M

LYRA Revenue FAQ

What is Lyra Therapeutics’s yearly revenue?

Lyra Therapeutics's yearly revenue for 2024 was $1.53M, representing a decrease of -1.54% compared to 2023. The company's yearly revenue for 2023 was $1.56M, representing an increase of 14.31% compared to 2022. LYRA's yearly revenue for 2022 was $1.36M, representing an increase of 378.25% compared to 2021.

What is Lyra Therapeutics’s quarterly revenue?

Lyra Therapeutics's quarterly revenue for Q3 2024 was $195K, a -67.39% decrease from the previous quarter (Q2 2024), and a -64.15% decrease year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $598K, a 12.41% increase from the previous quarter (Q1 2024), and a 30.57% increase year-over-year (Q2 2023). LYRA's quarterly revenue for Q1 2024 was $532K, a 264.38% increase from the previous quarter (Q4 2023), and a 29.76% increase year-over-year (Q1 2023).

What is Lyra Therapeutics’s revenue growth rate?

Lyra Therapeutics's revenue growth rate for the last 3 years (2022-2024) was 12.55%, and for the last 5 years (2020-2024) was 0%.